The University of Chicago Header Logo

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer. 2005 Sep 01; 104(5):1045-8.

View in: PubMed